Augmedix
AUGX
Augmedix trades at 1.9x EV/NTM revenue on a $108.0M enterprise value.
ARR ($M)
Net Dollar Retention
--
ARR Growth
--
EV / NTM Revenue
1.9x
Payback Period
EV / Run Rate
x
Price & Key Metrics
Price Performance
Company Details
Share Price: 2.35
Last Filing Date: 2024-06-30
Last Filing: Form
Founding Year: 2013
IPO Year: 2021
Description
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record.
Reporting Notes
Categories
Healthtech
Healthcare Services
B2B SaaS
Vertical SaaS
AI
Valuation
Market Cap: 115.723
Enterprise Value: 108.043
EV / Revenue Run Rate: --
EV / NTM Revenue: 1.9x
EV / 2026 Revenue Estimates: --
EV / 2027 Revenue Estimates: --
EV / 2028 Revenue Estimates: --
Key Business Metrics
Net Dollar Retention: --
Customers: --
ARR: --
ARR Growth %: --
ARR/Customer ($K): --
ARR/Employee ($K): --
Revenue
Revenue Run Rate: --
ARR: --
2026 Revenue Estimates: --
2027 Revenue Estimates: --
2028 Revenue Estimates: --
LTM Revenue: --
Last Year Run Rate: --
Growth
Revenue Growth: --
ARR Growth: --
Growth Persistence: --
2026 Revenue Growth Estimates: --
2027 Revenue Growth Estimates: --
2028 Revenue Growth Estimates: --
Financials
Quarterly
Calendar Year
Frequently Asked Questions
What multiple does Augmedix trade at?
Augmedix trades at 1.9x EV/NTM revenue, on an enterprise value of $108.0M.
Is Augmedix profitable?
For Augmedix, operating income was -$8.7M last quarter.
What sector is Augmedix in?
Public Comps classifies Augmedix under Healthtech, Healthcare Services, B2B SaaS, Vertical SaaS, and AI.
Where does Public Comps get Augmedix's data?
Figures come from Augmedix's own SEC filings, normalised into a consistent quarterly format and refreshed after each earnings release.